medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2011, Number 4

<< Back Next >>

Acta Ortop Mex 2011; 25 (4)

Fibrodysplasia ossificans progressiva syndrome. Report of three cases

Macías-Hernández G, Campos-Macías JL

Language: Spanish
References: 11
Page: 236-238
PDF size: 65.23 Kb.


ABSTRACT

Fibrodysplasia ossificans progressiva (FOP) syndrome is a very rare connective tissue disease characterized clinically by the progressive ossification of the soft tissues, usually with hallux malformation. Material and methods: Three patients diagnosed with FOP during 2006 were clinically, radiographically and tomographically assessed. Results: Three female patients ages 4, 6 and 12 years old with hallux deformity and indurated tumors of the trunk, neck and shoulders. Conclusion: FOP is a rare autosomal dominant genetic disease that manifests itself with ossification of the soft tissues, which progressively limits joint and trunk mobility.


REFERENCES

  1. University of Pennsylvania Orthopaedic Journal. Spring 1998; 11: 59-66.

  2. Kaplan FS, McCluskey W, Hahn G, et al: Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family. J Bone Jt Surg (Am) 75: 1214-20.

  3. Shafritz AB, Shore EM, Gannon FH, et al: Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 1996; 335: 555-61.

  4. Kaplan FS, Hahn GV, Zasloff MA: Heterotopic ossification: two rare forms and what they can teach us. J Am Acad Orthop Surg 1994; 2: 288-96.

  5. Kaplan FS, Tabas JA, Gannon FH, et al: The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J Bone Jt Surg 1993; 75(A) 75: 220-30.

  6. Santili CA, Akkari MA, Waisberg GA, Kessler CA, De Alcantara TA, Delai PL. Journal of Pediatric Orthopaedics B 2005; 14(4): 294-8.

  7. Smith R, Athanasou NA, Vipond SE: Fibrodysplasia (myositis) ossificans progressiva: clinicopathological features and natural history. Q J Med 1996; 89: 445-6.

  8. Cohen RB, Hahn GV, Tabas JA, et al: The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. J Bone Jt Surg (Am) 1993; 75: 215-9.

  9. Zasloff MA, Rocke OM, Crofford LJ, Hahn GV, Kaplan FS: Treatment of patients who have fibrodysplasia ossificans progressiva with isotretinoin. Clin Orthop Rel Res 1998; 346: 121-9.

  10. Rogers JG, Geho WB: Use and complications of high dose disodium etidronate therapy in fibrodisplasia ossificans progressive. J Pediatr 1977; 91: 1011-4.

  11. Brantus JF, Meunier PJ: Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia. 2006; 64(2): 183-5.




2020     |     www.medigraphic.com